AU2001250933A1 - Chitosan formulation with azelaic acid and other actives for the treatment of acne - Google Patents

Chitosan formulation with azelaic acid and other actives for the treatment of acne

Info

Publication number
AU2001250933A1
AU2001250933A1 AU2001250933A AU5093301A AU2001250933A1 AU 2001250933 A1 AU2001250933 A1 AU 2001250933A1 AU 2001250933 A AU2001250933 A AU 2001250933A AU 5093301 A AU5093301 A AU 5093301A AU 2001250933 A1 AU2001250933 A1 AU 2001250933A1
Authority
AU
Australia
Prior art keywords
actives
acne
treatment
azelaic acid
chitosan formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001250933A
Inventor
Jeffrey A. Gates
Dean A Oester
Rolf Wachter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis Corp
Original Assignee
Cognis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis Corp filed Critical Cognis Corp
Publication of AU2001250933A1 publication Critical patent/AU2001250933A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2913—Rod, strand, filament or fiber
    • Y10T428/298—Physical dimension

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AU2001250933A 2000-03-31 2001-03-22 Chitosan formulation with azelaic acid and other actives for the treatment of acne Abandoned AU2001250933A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09539603 2000-03-31
US09/539,603 US6451773B1 (en) 2000-03-31 2000-03-31 Chitosan formulation with azelaic acid and other actives for the treatment of acne
PCT/US2001/009225 WO2001074165A1 (en) 2000-03-31 2001-03-22 Chitosan formulation with azelaic acid and other actives for the treatment of acne

Publications (1)

Publication Number Publication Date
AU2001250933A1 true AU2001250933A1 (en) 2001-10-15

Family

ID=24151908

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001250933A Abandoned AU2001250933A1 (en) 2000-03-31 2001-03-22 Chitosan formulation with azelaic acid and other actives for the treatment of acne

Country Status (3)

Country Link
US (1) US6451773B1 (en)
AU (1) AU2001250933A1 (en)
WO (1) WO2001074165A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US6734210B2 (en) 2000-02-24 2004-05-11 Rolland F. Hebert Therapeutically improved salts of azelaic acid
WO2005107710A2 (en) * 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
US20050283004A1 (en) * 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
US20110135742A1 (en) * 2006-06-20 2011-06-09 The Regents Of The University Of California Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
CA2691272A1 (en) * 2007-06-29 2009-01-08 Union Carbide Chemicals & Plastics Technology Llc Hair styling and conditioning personal care films
JP2010532374A (en) * 2007-06-29 2010-10-07 ユニオン カーバイド ケミカルズ アンド プラスティックス テクノロジー エルエルシー Hair styling and conditioning personal care film
US7623332B2 (en) * 2008-01-31 2009-11-24 Commscope, Inc. Of North Carolina Low bypass fine arrestor
EP2116237A1 (en) * 2008-08-05 2009-11-11 Polichem SA Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
US20120108539A1 (en) * 2009-03-25 2012-05-03 Apex Laboratories Private Limited Medicinal Anti Acne Cream And A Process To Make It
WO2017116908A1 (en) * 2015-12-28 2017-07-06 Alumend, Llc Compositions and methods to affect skin irritation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
FR2623395B1 (en) 1987-11-24 1990-04-20 Oreal PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON BENZOYL PEROXIDE AND QUATERNARY AMMONIUM LIPOPHILIC SALICYLATES AND THEIR USE, ESPECIALLY IN THE TREATMENT OF ACNE
US5023090A (en) 1989-08-16 1991-06-11 Levin Robert H Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE
US5260292A (en) 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
US5505949A (en) 1994-10-13 1996-04-09 Benitez; Juan E. Topical treatment for acne
DE4442987C2 (en) * 1994-12-02 1997-04-17 Henkel Kgaa Cationic chitin breakdown products
US5665364A (en) * 1995-07-24 1997-09-09 The Procter & Gamble Company Compositions for topical delivery of active ingredients

Also Published As

Publication number Publication date
US6451773B1 (en) 2002-09-17
WO2001074165A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
AU2002362482A1 (en) Acne treatment using oleanolic acid
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU5455200A (en) The use of encapsulated acid in acid fracturing treatments
AU4367000A (en) Perfluorinated acid fluorides and preparation thereof
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2003288126A1 (en) Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents
AU2002314847A1 (en) Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
AU2001274001A1 (en) Ortho-substituted anthranilic acid amides and their use as medicaments
AU7067200A (en) Skin care compositions and treatments
AU2001278772A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
AU2001250933A1 (en) Chitosan formulation with azelaic acid and other actives for the treatment of acne
AU5647199A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
AU6997200A (en) No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product
AU2001283344A1 (en) Dermatological formulation
AU6038601A (en) Amino acid derivatives and their use as medicines
AU5443499A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
AU2001254961A1 (en) Agrochemical spray treatment and spray formulations
AU2003219511A1 (en) Carnitine in the treatment of geriatric depression
AU4426801A (en) Composition based on sphingolipid and beta-hydroxy-acid for skin care
AU5327800A (en) Methods for treating skin with 3-hydroxy benzoic acid and related compositions
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU2002361096A1 (en) Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
AU2001255487A1 (en) Salicylic acid acne spray formulations and methods for treating acne with same
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
AU7608100A (en) 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors